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 INTRODUCTION
Gallbladder cancer (GBC) is a rare condition and ranks fifth in neoplasms of the gastrointestinal tract. 
However, it is the most frequent malignant neoplasm 
that affects the bile ducts1. The most common histological 
type is adenocarcinoma, representing approximately 
90% of the cases and classified as papillary, tubular 
and mucinous. The frequency of the other histological 
types (anaplastic, squamous and adenosquamous 
carcinoma) is extremely low2. GBC affects patients older 
than 60 years. The incidence in women is greater when 
compared to male patients in the approximate ratio of 
3:13,4. Among its risk factors, the most common are 
cholecystolithiasis, followed by the presence of polyps in 
the gallbladder and the gallbladder in porcelain. Several 
studies have demonstrated that the infection of the bile 
ducts with Salmonella sp. and Helicobacter pylori would 
be related to the increased incidence of the disease. The 
genetic component is also an important risk factor for 
the development of this neoplasm6-8.
The incidence of GBC is variable when 
analyzed in different geographic regions and in certain 
ethnic groups. It is low in Western countries such as 
the United States, where it affects 0.9 women and 0.5 
men per 100,000 inhabitants. The United Kingdom 
also has a similar incidence. However, indigenous 
populations of the US, Hispanic American countries like 
Mexico, Chile, Peru, northern Argentina and Bolivia, 
Ecuador, Colombia, some Eastern European countries 
like Poland and Slovakia and in Asia, Japan, India and 
Pakistan, have a high incidence of GBC9.
Due to the disease’s characteristics, the lack 
of specificity of the clinical picture and, fundamentally, 
its late diagnosis, the prognosis of gallbladder cancer 
is poor10. In the vast majority of cases, the diagnosis 
comes late and in advanced stages, thus compromising 
treatment results and consequently increasing 
morbidity and mortality11. It is estimated that 85% of 
patients die one year after being diagnosed12.
In Brazil, there are no population studies 
analyzing the incidence of gallbladder cancer. There 
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A B S T R A C T
Objective: to evaluate the prevalence of gallbladder carcinoma in patients submitted to cholecystectomy for chronic cholecystitis at the 
University Hospital of the State University of Campinas. Methods: we conducted a retrospective prevalence study through the analysis 
of histological specimens from January 2010 to May 2015. Results: we analyzed 893 patient reports. Emergency cholecystectomies 
amounted to 144, and elective ones, 749 (16.2% and 83.8%, respectively). Regarding gender, 72.8% were female and 27.2% male. 
Gallbladder adenocarcinoma occurred in 12 patients (1.3%) and non‑Hodgkin’s lymphoma in one (0.1%). In patients with cancer, seven 
(53.8%) were associated with cholelithiasis and two (15.3%) with gallbladder polyps. Conclusion: prevalence results of gallbladder ad‑
enocarcinoma in this study were similar to those of Western studies and the main risk factor was cholelithiasis, followed by the presence 
of gallbladder polyps.
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are, however, some studies of regional prevalence 
and incidental diagnosis, with different results when 
compared with each other13-17. Therefore, the real 
incidence of gallbladder cancer in our country remains 
unknown.
The objective of this study is to analyze 
the prevalence of gallbladder cancer in patients 
undergoing cholecystectomy, as well as risk factors 
associated with GBC, in the Clinics Hospital of the 
Faculty of Medical Sciences of the State University of 
Campinas – UNICAMP.
 METHODS
We conducted a cross-sectional, descriptive 
study, with retrospective data collection. We reviewed 
the reports of histopathological specimens from patients 
submitted to elective or emergency cholecystectomy 
and sent to the Department of Pathology of the 
Clinics Hospital, UNICAMP, from January 2010 to 
May 2015. In reports with diagnosis of gallbladder 
neoplasia, we performed an analysis of the medical 
record in the medical archive service. This project was 
approved by the Ethics in Research Committee and is 
registered in the “Plataforma Brasil” under the CAAE 
number 48103614.6.0000.5404. We collected the 
data in protocol sheets and organized them into Excel 
spreadsheets. We performed the statistical analysis 
with the software SPSS Statistics 20.0. We present 
quantitative variables as mean ± standard deviation, 
and qualitative variables, as frequency and percentage.
 RESULTS
During the study period, 893 cholecystectomies 
were performed. Of these, 749 (83.8%) were elective 
and 144 (16.2%) were emergency ones. According 
to the gender, 650 (72.8%) were female and 243 
(27.2%), male.
Upon analyzes of the histopathology reports 
of the surgical specimens, we found that 13 (1.4%) 
had a diagnosis of gallbladder neoplasia. Regarding 
histological type, 12 (92.3%) patients had gallbladder 
adenocarcinoma, and one (7.7%), non-Hodgkin’s 
lymphoma (Table 1). The study group had a mean age 
of 60.23 years, with a variability of 35 to 85 (median 
age 59 years and standard deviation 12.93). As for 
gender, 10 (77%) patients were women, and three 
(23%), men (Table 2).
The analysis of the clinical presentation of 
such patients in the preoperative period showed that 
seven (53.84%) had moderate abdominal pain located 
in the right hypochondrium; two patients (15,38) 
presented with nonspecific dyspeptic condition; 
another two (15.38%) in addition to complaints 
of abdominal pain, had jaundice and coluria; one 
patient (7.7%) was admitted to the emergency room 
with acute cholangitis; and one patient (7.7%) was 
asymptomatic.
Regarding the preoperative ultrasonographic 
findings, four patients (30.8%) had a diagnosis of 
cholecystolithiasis, and two (15.4%), of polyps in the 
gallbladder. In four (30.8%), there was suspicion of 
gallbladder neoplasia. Finally, three other patients 
(23%) were suspected of having gallbladder neoplasia 
and cholecystolithiasis. In the study group, seven 
Table 1 - Gallbladder neoplasms’ histological types.
Histological type N %
Adenocarcinoma 12 92.3
Non-Hodgkin’s Lymphoma 1 7.7
Total 13 100






Inflammatory cholecystopathy 880 (98.6)
Neoplasm 13 (1.4)
Age M* 59 (35-85). SD** ±12.93
Total 893 (100)
* M = median, ** SD = standard deviation.
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patients had a suspicion of gallbladder cancer in 
the preoperative period, corresponding to 53.84%. 
However, six patients (46.16%) had their diagnosis 
confirmed only after the histopathological analysis 
of the surgical specimen. All surgeries of the studied 
group were performed in an elective manner.
 DISCUSSION
Bile duct neoplasms are rare conditions 
that in most cases originate from the biliary lining 
epithelium, being classified according to their location 
in intrahepatic, extrahepatic and of the gallbladder, 
the latter being the most common. The predominant 
histological type is adenocarcinoma18,19. In the present 
study, only one patient (7.7%) presented a different 
histological type. Because of its late diagnosis and the 
tumor biological behavior, GBC continues to display 
poor prognosis and low long-term survival20,21. The 
incidental diagnosis of GBC has apparently increased, 
ranging from 0.3% to 2% of cholecystectomies due to 
cholecystolithiasis22.
In our series, all patients were treated 
electively. In two patients, the approach was 
laparoscopic, and in eleven, laparotomic. In seven 
patients (53.84%), there was a diagnostic suspicion 
of neoplasia still in the preoperative period. I four 
of these, cholecystectomy was performed with 
regional lymphadenectomy associated with resection 
of the extrahepatic biliary tract with Roux-en-Y 
biliodigestive anastomosis. Three of them, in addition 
to the aforementioned procedures, were submitted 
to wedge resection of the gallbladder’s hepatic 
bed. In six patients (46.16%), the diagnosis was 
defined after a histopathological study of specimens 
from patients undergoing cholecystectomy due 
to cholecystolithiasis. Of these, five had mucosal-
restricted neoplasia (carcinoma in situ) and one had a 
diagnosis of non-Hodgkin’s lymphoma, being referred 
to the Oncology service for adjuvant therapy. The 
incidental diagnosis in patients electively submitted 
to cholecystectomy due to cholecystolithiasis in this 
sample was 0.67%, similar to those published in 
other Western countries23-25. Recently, Martins-Filho 
et al., in a study of the population of the State of 
Pernambuco, reported prevalence for incidental GBC 
of 0.34% 26.
Gallbladder cancer affects patients over 50 
years of age at approximately 90% of the time, and 
female. In our study, 77% of the patients were female, 
with a mean of 60.23 years of age. Of these, 84% 
were older than 50 years.
Due to the lack of specificity of the clinical 
picture and the absence of symptoms suggestive of 
the disease in the early stages, the diagnosis of GBC 
is most often reached late and at an advanced stage. 
This invariably compromises prognosis, increases 
treatment morbidity and decreases long-term survival, 
of 5% when analyzed in a global manner. In this study, 
in 53.8% of cases the disease was advanced at the 
time of surgery. Among the symptoms these patients 
usually present with, abdominal pain localized mainly 
in the right hypochondrium, of continuous character, 
associated to the weight loss, are the most frequent. 
The presence of cholestatic symptoms usually suggests 
advanced disease. In this study, abdominal pain was 
present in all of those in whom the neoplasia was 
suspected in the preoperative period, followed by the 
presence of dyspeptic symptoms in 15.38%. In three 
patients, cholestatic symptoms were predominant.
The incidence of this neoplasia varies 
according to the region studied. Hispanic-American 
populations have a high incidence. In our continent, it 
is noteworthy the high incidence in countries such as 
Chile, 25/100,000 women and 9/100,000 men, and in 
Native American of the New Mexico, of 14.5/100,000. 
In Europe, Poland shows an incidence of 14/100,000. 
In Asia, India has 10/100,000 and Japan, 7/100,000, 
figures very different from those published in Western 
populations. This population variability of the disease 
reinforces the theory of the genetic component in the 
disease’s etiology.
In our country, there are no population 
studies assessing GBC incidence. The few that exist 
analyzed the disease’s prevalence in certain regions 
of the country or the incidental diagnosis of this 
neoplasia. Jukemura et al.15, studying 475 patients who 
underwent cholecystectomy due to cholecystolithiasis 
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in São Paulo, found incidental GBC in 1.68%. Weston 
et al.16 showed an incidental diagnosis of the disease 
of 0.012% in a study carried out in a population of 
the State of Rio Grande do Sul. Torres et al.17, in a 
study similar to ours, found a prevalence of 2.3% 
in patients from São Luiz, Sate of Maranhão. The 
difference between the values  in the different 
population samples studied once again suggests the 
importance of the ethnic-genetic component of the 
neoplasia. It is possible to infer that the intermediate 
prevalence of 1.4% found in our sample is explained 
by the miscegenation characteristics of the Campinas 
population, similar to that of the city of São Paulo.
Among the risk factors associated 
with gallbladder cancer, the most important is 
cholecystolithiasis, which is present in more than 70% 
of the time. In our country, Ziliotto Jr et al.27 found an 
association of chronic cholecystolithiasis and gallbladder 
neoplasia in 40.9% of the cases. Carneiro et al.14, in 
1994, found a 68% association. Ours was 53%. Another 
risk factor related to GBC is the presence of gallbladder 
adenomatous polyps, considered pre-neoplastic lesions 
for the development of the disease, representing 30.8% 
of cases and being directly related to their size. In our 
sample, 15.4% had a diagnosis of gallbladder polyp at 
the ultrasound examination, which was confirmed in 
the histopathological study. Other risk factors such as 
porcelain gallbladder, anatomical anomalies of the biliary 
tract, Salmonella sp. and Helicobacter pylori infection, 
and genetic alterations, were not studied in our series.
The main limitation of this study is its 
retrospective design, which negatively influences the 
quality of data available. In addition, since the global 
incidence of GBC is low, the small absolute number of 
patients affected by it also makes it difficult to perform 
deeper analyzes. On the other hand, the availability of a 
large absolute number of histopathological specimens, 
in a study carried out in a regional and state reference 
service, partially attenuates this limitation. Due to 
Brazil’s continental dimensions and ethnic diversity, 
there is a need for multicenter studies with larger 
population samples including the different geographic 
regions, to determine the real incidence of gallbladder 
cancer in our country.
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